Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial

In conclusion, mEHT therapy with weekly paclitaxel or cisplatin appeared safe and warrants further investigation. The present trial was registered with www.clinicaltrials.gov on January 22, 2015 (trial registration no. NCT02344095).PMID:34055086 | PMC:PMC8145814 | DOI:10.3892/etm.2021.10219

Source: Experimental and Therapeutic Medicine - May 31, 2021 Category: General Medicine Authors: Kidong Kim Jae-Hoon Kim Seung Cheol Kim Yong Beom Kim Byung-Ho Nam Jae Hong No Hanbyoul Cho Woong Ju Dong Hoon Suh Yun Hwan Kim Source Type: research